These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


586 related items for PubMed ID: 14700163

  • 1. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
    Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S656-60. PubMed ID: 14700163
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [Abstract] [Full Text] [Related]

  • 3. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 4. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin failure and retreatment in Kawasaki disease.
    Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C.
    Pediatr Cardiol; 2003 Feb; 24(2):145-8. PubMed ID: 12457253
    [Abstract] [Full Text] [Related]

  • 6. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 7. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD, Zhao D, DU JB, Lu S, Yi JM, Hou AC, Zhou ZS, Ding GF, Beijing Kawasaki Disease Epidemilogy Study Grou.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3119-21. PubMed ID: 18269869
    [Abstract] [Full Text] [Related]

  • 8. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 27; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 9. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
    Sittiwangkul R, Pongprot Y, Silvilairat S, Phornphutkul C.
    Singapore Med J; 2006 Sep 27; 47(9):780-4. PubMed ID: 16924360
    [Abstract] [Full Text] [Related]

  • 10. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    Pediatr Allergy Immunol; 2010 May 27; 21(3):515-21. PubMed ID: 20546528
    [Abstract] [Full Text] [Related]

  • 11. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin.
    Tsai MH, Huang YC, Yen MH, Li CC, Chiu CH, Lin PY, Lin TY, Chang LY.
    J Pediatr; 2006 Jan 27; 148(1):38-43. PubMed ID: 16423595
    [Abstract] [Full Text] [Related]

  • 12. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
    Simonini G, Masi L, Giani T, Piscitelli E, Cimaz R, Vierucci S, Brandi ML, Falcini F.
    J Rheumatol; 2005 Nov 27; 32(11):2233-8. PubMed ID: 16265708
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
    Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S.
    J Rheumatol; 2012 Apr 27; 39(4):864-7. PubMed ID: 22337241
    [Abstract] [Full Text] [Related]

  • 14. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
    Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT.
    Pediatr Infect Dis J; 2004 Jan 27; 23(1):52-5. PubMed ID: 14743047
    [Abstract] [Full Text] [Related]

  • 15. Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease.
    Kashef S, Safari M, Amin R.
    Kaohsiung J Med Sci; 2005 Sep 27; 21(9):401-4. PubMed ID: 16248123
    [Abstract] [Full Text] [Related]

  • 16. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Sep 27; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 17. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, Wang L, Wang CL.
    Pediatr Allergy Immunol; 2007 Jun 27; 18(4):354-9. PubMed ID: 17584314
    [Abstract] [Full Text] [Related]

  • 18. A cost-benefit analysis of intravenous immunoglobulin treatment in children with Kawasaki disease.
    Arj-ong S, Chotivitayatarakorn P, Lertsapcharoen P, Khongphatthanayothin A, Thisyakorn C.
    J Med Assoc Thai; 2003 Jun 27; 86 Suppl 2():S179-88. PubMed ID: 12929987
    [Abstract] [Full Text] [Related]

  • 19. Kawasaki disease in central area of Northeast Thailand.
    Panamonta M, Chaikitpinyo A, Durongpisitkul K, Somchit S, Petcharatana S, Wongswadiwat Y, Kosalaraksa P, Lumbiganon P.
    J Med Assoc Thai; 2004 Aug 27; 87(8):887-90. PubMed ID: 15471291
    [Abstract] [Full Text] [Related]

  • 20. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
    Abe J, Ebata R, Jibiki T, Yasukawa K, Saito H, Terai M.
    J Allergy Clin Immunol; 2008 Nov 27; 122(5):1008-1013.e8. PubMed ID: 18930517
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.